157 It should be noted that cellular senescence should not be conflated with the broader concept of aging, as the latter encompasses a more comprehensive range of phenomena beyond just cellular senescence
Read the full post: #ObesityMedicine #MetabolicHealth To view or add a comment, sign in How should clinicians and health systems balance weight loss outcomes with broader measures such as quality of life, long-term health benefits, and patient preferences
However, Novo said it will continue to manage shipments of the drugs 0.25 mg starter dose to responsibly initiate patients on treatment. Novo is the maker of the wildly popular Ozempic and its weight loss counterpart Wegovy, both formulations of semaglutide
13 (Suppl 1), 22
In my opinion, taking any approved supplement, as long as the patient follows instructions and the recommended dose size, in conjunction with semaglutide, could be beneficial. The bottom line Semaglutide and lipotropic injections are both seen as potential weight loss solutions
However, there was no mention of follow-up results for this patient after the initial treatment period